Tyrosine Kinase Inhibitors

• A9812

  AZD-1480

  JAK1/2 inhibitor.

  ≥99%
• A9600

  AZD-3463

  ALK and IGF-1R inhibitor.

  ≥99%
• A9813

  AZD-8931

  Inhibitor of EGFR, HER2, and HER3.

  ≥98%
• A985134

  AZD-9291

  EGFR inhibitor.

  ≥99%
• B022691

  Baricitinib

  Selective and reversible JAK inhibitor.

  ≥98%
• B030966

  BAY 11-7082

  inhibits inflammatory signaling

  ≥98%
• B242042

  BGB-283

  Dual RAF/EGFR inhibitor.

  ≥98%
• B5072

  BMS-754807

  InsR and IGF-1R inhibitor.

  ≥99%
• B4974

  BMS-777607

  MET and Ron inhibitor.

  ≥99%
• B4976

  BMS-794833

  MET, VEGFR2, Ron, Axl, FLT3 inhibitor.

  ≥98%
• B5000

  BMS-911543

  JAK2 inhibitor.

  ≥99%
• B5874

  Bosutinib

  Src and Abl inhibitor.

  ≥98%
• B5875

  Bosutinib, structural isomer

  Bosutinib isomer; Src and Abl inhibitor.

  ≥98%
• C0006

  Cabozantinib

  VEGFR2, c-Met, RET inhibitor.

  ≥98%
• C0252

  Canertinib Dihydrochloride

  EGFR inhibitor.

  ≥98%
• C104761

  CCT-196969

  pan-Raf inhibitor.

  ≥98%
• C1613

  Cediranib

  VEGFR inhibitor.

  ≥98%
• C179602

  CEP-28122

  ALK inhibitor.

  ≥98%
• C179604

  CEP-28122 Mesylate

  ALK inhibitor.

  ≥98%
• C179603

  CEP-37440 Hydrochloride

  Inhibitor of FAK and ALK.

  ≥99%
• C5592

  CNX-774

  BTK inhibitor.

  ≥98%
• C5600

  CO-1686

  EGFR (WT, T790M) inhibitor.

  ≥98%
• C6935

  Crizotinib

  ALK, ROS1, c-MET inhibitor.

  ≥98%
• C822706

  Curvularin

  Macrocyclic lactone.

  ≥98%
• C9876

  CYT-387

  JAK2 inhibitor.

  ≥98%

Showing 26–50 of 145 results